CMPX vs LOW · $367.4M cap vs P/E 18, rev $86.29B
Compass Therapeutics Inc. (CMPX) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
CMPX does not have a complete income-statement cache yet.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
CMPX currently screens at market cap $367.4M. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the CMPX and LOW stock pages for the full models.
Not investment advice.